Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.295
+0.007 (2.25%)
At close: Mar 9, 2026, 4:00 PM EDT
0.294
-0.001 (-0.41%)
After-hours: Mar 9, 2026, 7:57 PM EDT
Plus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 52 | 7 | 8 | 11 | 16 | 10 | |
| Market Cap Growth | 635.52% | -14.33% | -25.69% | -33.96% | 67.05% | 6.69% | |
| Enterprise Value | 42 | 5 | 1 | -4 | 2 | 9 | |
| Last Close Price | 0.30 | 1.15 | 1.75 | 4.75 | 15.75 | 30.30 | |
| PS Ratio | 9.93 | 1.16 | 1.61 | 47.55 | - | 31.86 | |
| PB Ratio | 7.69 | -0.76 | -5.87 | 1.65 | 1.49 | 3.19 | |
| P/TBV Ratio | 12.12 | - | - | 1.78 | 1.55 | 3.75 | |
| EV/Sales Ratio | 8.00 | 0.93 | 0.30 | - | - | 29.48 | |
| Debt / Equity Ratio | 1.27 | -0.38 | -3.10 | 0.88 | 0.65 | 2.31 | |
| Net Debt / Equity Ratio | -2.01 | 0.03 | 3.24 | -1.94 | -1.05 | -0.44 | |
| Net Debt / EBITDA Ratio | 0.79 | 0.02 | 0.35 | 0.65 | 0.97 | 0.16 | |
| Net Debt / FCF Ratio | 0.65 | 0.02 | 0.34 | 0.93 | 1.09 | 0.16 | |
| Asset Turnover | 0.41 | 0.65 | 0.28 | 0.01 | - | 0.02 | |
| Quick Ratio | 1.22 | 0.27 | 0.80 | 1.53 | 3.14 | 0.98 | |
| Current Ratio | 1.29 | 0.34 | 0.92 | 1.84 | 3.36 | 1.07 | |
| Return on Equity (ROE) | - | - | -522.50% | -234.65% | -193.25% | -393.27% | |
| Return on Assets (ROA) | -65.58% | -101.93% | -47.23% | -53.74% | -44.65% | -31.14% | |
| Return on Capital Employed (ROCE) | -266.20% | 164.80% | -2015.30% | -164.10% | -75.60% | -246.90% | |
| Earnings Yield | -39.40% | -191.39% | -168.24% | -190.35% | -83.08% | -85.36% | |
| FCF Yield | -30.21% | -157.80% | -164.38% | -126.56% | -64.63% | -88.32% | |
| Buyback Yield / Dilution | -682.06% | -145.18% | -79.45% | -117.18% | -173.03% | -219.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.